Factor Vii Deficiency
📧 Sign up to get email alerts when something new happens for Factor Vii Deficiency.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2022-09-27EMA Application withdrawn: HemAryo (eptacog alfa (activated)) — UGA Biopharma
EMA withdrawn the application for HemAryo (eptacog alfa activated) by UGA Biopharma for hemophilia A, hemophilia B, and factor VII deficienc…